DIAGNOSTIC ARTHROSCOPY VERSUS ARTHROCENTESIS AS INITIAL TREATMENT FOR ARTHRALGIA OF THE TEMPOROMANDIBULAR JOINT A mono-center single-blind randomized controlled trial

Recruiting

• Conditions: Degeneration of the jaw joint; disc displacement; 10005944

• Registration Number: NL-OMON50917
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 140

Inclusion Criteria

- Patients aged 18 years or older.

- Arthralgia of the Temporomandibular joint (TMJ), proven with a diagnostic
intra-articular injection with Ultracain DS Forte.

- TMJ pain still present after two weeks of NSAIDs

- Symptoms presenting unilaterally or bilaterally with at least one TMJ with a
Visual Analog Scale-score < 30 mm during movement or function, after
anesthetizing the contralateral joint.

Exclusion Criteria

- Systemic rheumatic disease
- Bony ankylosis of the Temporomandibular Joint (TMJ)
- Congenital or acquired dentofacial deformity
- History of jaw trauma that resulted in jaw or joint pain, bony changes or
mandibular growth restriction
- Prior arthrocentesis, (diagnostic) arthroscopy or open-TMJ surgery
- Psychiatric disorder (as diagnosed by a physician)
- Unwillingness to receive one of the study treatments
- Pregnancy at time of treatment
- Concurrent use of steroids, muscle relaxants or anti-inflammatory drugs other
than the previously prescribed NSAIDs
- Incompetence to speak the Dutch or English language
- Coagulation disorders, diabetes mellitus type I or II, kidney failure, heart
failure, cardiac ischemia, hypertension and history of HIV.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- Pain during mandibular movement or function using the VAS</p><br>